Skip to content

Kalehua Capital Management LLC

Follow

13F filer, CIK 2106181, DALLAS, TX

Kalehua Capital Management LLC reported $132,396,155 across 22 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-13. Its ten largest share positions make up 80.75% of the portfolio.

Accepted , ingested 13F-HR 0002106181-26-000010

Period
2026-09-30
Reported value
$132M
Holdings
22
Top 10 weight
80.75%
New
8
Sold out
12

Largest buys vs the previous quarter

SecurityShares changeApprox. value
KRSAnew+442,653$14.2M
BETRFnew+27,710,000$6.68M
OBXnew+416,649$5.72M
ATTOnew+200,000$3.43M
DMRAnew+139,000$2.96M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
CMPSexited-819,692-$11.6M
BOXXreduced-77,717-$9.2M
SIONexited-197,072-$8.67M
PHVSexited-198,772-$6.87M
KPTIexited-685,644-$6.7M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0002106181-26-000010, largest first. % of portfolio is the value over $132,396,155, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
MANEVERADERMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 145,695 shares; 2026Q2: 145,695 shares; 2026Q3: 145,695 shares 145,695$17.7M13.34%0Timeline
BOXXEA SERIES TRUSTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 230,787 shares; 2026Q1: 218,278 shares; 2026Q2: 226,188 shares; 2026Q3: 148,471 shares 148,471$17.6M13.28%-77,717Timeline
KRSAKORSANA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 442,653 shares 442,653$14.2M10.7%newTimeline
XFORX4 PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 3,722,840 shares; 2026Q1: 3,722,840 shares; 2026Q2: 3,722,840 shares; 2026Q3: 3,722,840 shares 3,722,840$10.8M8.15%0Timeline
ACRSACLARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 1,832,365 shares; 2026Q2: 1,832,365 shares; 2026Q3: 1,832,365 shares 1,832,365$9.64M7.28%0Timeline
SRZNSURROZEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 385,178 shares; 2026Q1: 385,178 shares; 2026Q2: 385,178 shares; 2026Q3: 286,092 shares 286,092$9.21M6.95%-99,086Timeline
IKTINHIBIKASE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 1,750,000 shares; 2026Q1: 3,821,890 shares; 2026Q2: 3,821,890 shares; 2026Q3: 3,821,890 shares 3,821,890$7.85M5.93%0Timeline
SEPNSEPTERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 194,544 shares; 2026Q1: 194,544 shares; 2026Q2: 194,544 shares; 2026Q3: 194,544 shares 194,544$7.61M5.75%0Timeline
BETRFBETTERLIFE PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 27,710,000 shares 27,710,000$6.68M5.04%newTimeline
OBXOBSIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 416,649 shares 416,649$5.72M4.32%newTimeline
IFRXINFLARX NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,897,769 shares; 2026Q3: 2,921,095 shares 2,921,095$5.26M3.97%+23,326Timeline
KRROKORRO BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 109,376 shares; 2026Q2: 405,040 shares; 2026Q3: 473,595 shares 473,595$4.69M3.54%+68,555Timeline
ATTOATTOVIA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 200,000 shares 200,000$3.43M2.59%newTimeline
DMRADAMORA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 139,000 shares 139,000$2.96M2.23%newTimeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 291,109 shares; 2026Q2: 79,407 shares; 2026Q3: 79,407 shares 79,407$1.92M1.45%0Timeline
GOSSGOSSAMER BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 139,366 shares 139,366$1.65M1.25%newTimeline
MISTMILESTONE PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,269,237 shares; 2026Q3: 1,651,258 shares 1,651,258$1.43M1.08%+382,021Timeline
LONALEONABIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 393,701 shares; 2026Q1: 393,701 shares; 2026Q2: 393,701 shares; 2026Q3: 393,701 shares 393,701$1.41M1.06%0Timeline
RNAATRIUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 112,652 shares 112,652$933K0.7%newTimeline
TILINSTIL BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 183,030 shares; 2026Q2: 99,600 shares; 2026Q3: 99,600 shares 99,600$721K0.54%0Timeline
ATYRATYR PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,788,167 shares; 2026Q3: 1,829,513 shares 1,829,513$554K0.42%+41,346Timeline
KZIAKAZIA THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 56,013 shares 56,013$537K0.41%newTimeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
CMPSCOMPASS PATHWAYS PLC819,692$11.6Mshares
SIONSIONNA THERAPEUTICS INC197,072$8.67Mshares
PHVSPHARVARIS N V198,772$6.87Mshares
KPTIKARYOPHARM THERAPEUTICS INC685,644$6.7Mshares
CYCNCYCLERION THERAPEUTICS INC1,651,350$5.6Mshares
DMRADAMORA THERAPEUTICS INC139,000$3.62Mshares
MLTXMOONLAKE IMMUNOTHERAPEUTICS175,734$3.42Mshares
ANLADLAI NORTYE GROUP LTD226,415$2.6Mshares
TYRATYRA BIOSCIENCES INC74,465$2.38Mshares
NVCTNUVECTIS PHARMA INC100,000$1.84Mshares
GOSSGOSSAMER BIO INC11,149,363$1.84Mshares
TCRXTSCAN THERAPEUTICS INC454,876$446Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0002106181-26-000010 base2026-11-13